Diagnosis and Management of Leukemic and Lymphomatous Meningitis.

about

Diagnosis and Management of Leukemic and Lymphomatous Meningitis.

Item

http://www.wikidata.org/entity/Q39126738

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Diagnosis and Management of Leukemic and Lymphomatous Meningitis.

@en

Diagnosis and Management of Leukemic and Lymphomatous Meningitis.

@nl

type

Item

label

Diagnosis and Management of Leukemic and Lymphomatous Meningitis.

@en

Diagnosis and Management of Leukemic and Lymphomatous Meningitis.

@nl

prefLabel

Diagnosis and Management of Leukemic and Lymphomatous Meningitis.

@en

Diagnosis and Management of Leukemic and Lymphomatous Meningitis.

@nl

P1476

Diagnosis and Management of Leukemic and Lymphomatous Meningitis

@en

P2093

Claudio Anasetti

http://www.w3.org/2001/XMLSchema#string

Ernesto Ayala

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system

Primary leptomeningeal lymphoma: International Primary CNS Lymphoma Collaborative Group report.

Primary CNS lymphoma with intraocular involvement: International PCNSL Collaborative Group Report.

Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01.

Protein biomarker identification in the CSF of patients with CNS lymphoma.

The changing incidence of primary central nervous system lymphoma is driven primarily by the changing incidence in young and middle-aged men and differs from time trends in systemic diffuse large B-cell non-Hodgkin's lymphoma.

Leptomeningeal metastases: comparison of clinical features and laboratory data of solid tumors, lymphomas and leukemias.

Augmented and standard Berlin-Frankfurt-Munster chemotherapy for treatment of adult acute lymphoblastic leukemia.

High-dose methotrexate and rituximab with deferred radiotherapy for newly diagnosed primary B-cell CNS lymphoma

The presence of central nervous system disease at diagnosis in pediatric acute myeloid leukemia does not affect survival: a Children's Oncology Group study.

P304

33-41

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/107327481702400105

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hemant S Murthy

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28178710

http://www.w3.org/2001/XMLSchema#string

P921

leukemia

meningitis